None listed
Conditions
Interventions
Procedure/Surgery : 1. Experimental group: A total of four acupotomy treatments will be conducted(4 times for 2 weeks). Two or three needles will be inserted 20-30 mm away from the spinous process of
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Who aged 19-70 years 2) Who was confirmed diagnosis of lumbar herniated disc by CT(Computed Tomography) or MRI(magnetic resonance imaging) within 5 years 3) Who with symptoms of lumbar dics herniation, such as low back pain, radiating pain in low extremity, paraesthesia in lower extremity, weakness in lower extremity, and etc. 4) Who scored more than 30mm on VAS(Visual Analogue Scale) at the time of screening 5) Who have no problems with language, expression and concentration 6) Who be able and willing to comply with intervention and follow-up evaluation 7) Who voluntary agreement via written informed consent after being provided with an explanation regarding the purpose and characteristics of this study
Exclusion criteria
Exclusion criteria: 1) Hypersensitive reaction to previous acupuncture treatment, metal allergy, severe atopy, keloid, and other skin hypersensitivities 2) Patients requiring surgery because of cauda equina syndrome, or neurological symptoms such as motor and/or sensory paralysis 3) History of plate internal fixation or spinal fusion operation 4) Suffering from pain in another region that is greater than the pain of lumbar and/or lower extremity region 5) Using drug to pain relief, such as narcotic analgesics, anticonvulsants, corticosteroids, and etc. 6) History of participainting another clinical trial with intervention in past 3 months 7) Pregnant woman, lactating woman, or woman in childbearing years who plans on being pregnant 8) History of neurotic or major psychiatric disability, or alcoholism or drug abuse, or severe underlying disease requiring active treatment or being treated currently 9) Those who have a hemorrhagic disease or cardiovascular disease, and/or factors that can affect hemostasis such as anti-coagulant or anti-platelet drug 10) Patients who are considered to be inappropriate for the study by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Roland Morris Disability Questionnaire (RMDQ);Modified-Modified Schober Test (MMST);Quality of life(EuroQol five dimensions questionnaire; EQ-5D);Clinical relevance (MCID ratio);PGIC(Patient Global Impression of change);Safety assessment (Adverse effect) | — |
Countries
Korea, Republic of
Contacts
Public ContactEunseok Kim
Dunsan Korean Medicine Hospital of Daejeon University
Outcome results
None listed